Business Description
Vivanza Biosciences Ltd
ISIN : INE984E01035
Compare
Compare
Traded in other countries / regions
530057.India IPO Date
1995-05-10Description
Vivanza Biosciences Ltd is a pharmaceutical company. Its core focus areas include research and development, manufacturing, and the distribution of a wide range of pharma and pharmaceutical products. The company's product portfolio includes Medical examination gloves, Injections, Veterinary feeds, and others.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.24 | |||||
| Debt-to-Equity | 1.12 | |||||
| Debt-to-EBITDA | 5.9 | |||||
| Interest Coverage | 2.18 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.1 | |||||
| Beneish M-Score | -2.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 41.2 | |||||
| 3-Year EBITDA Growth Rate | 23.1 | |||||
| 3-Year EPS without NRI Growth Rate | 94.6 | |||||
| 3-Year FCF Growth Rate | 126.9 | |||||
| 3-Year Book Growth Rate | 13.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.94 | |||||
| 9-Day RSI | 26.59 | |||||
| 14-Day RSI | 30.43 | |||||
| 6-1 Month Momentum % | -38.88 | |||||
| 12-1 Month Momentum % | -61.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.29 | |||||
| Quick Ratio | 1.13 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 42.72 | |||||
| Days Sales Outstanding | 251.38 | |||||
| Days Payable | 193.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 8.77 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 8.07 | |||||
| Operating Margin % | 4.09 | |||||
| Net Margin % | 1.52 | |||||
| FCF Margin % | 9.53 | |||||
| ROE % | 7.05 | |||||
| ROA % | 1.36 | |||||
| ROIC % | 4.5 | |||||
| 3-Year ROIIC % | 19.74 | |||||
| ROC (Joel Greenblatt) % | 16.56 | |||||
| ROCE % | 13.35 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 41.44 | |||||
| Shiller PE Ratio | 105.62 | |||||
| Price-to-Owner-Earnings | 9.43 | |||||
| PS Ratio | 0.7 | |||||
| PB Ratio | 3.22 | |||||
| Price-to-Tangible-Book | 4.97 | |||||
| Price-to-Free-Cash-Flow | 7.43 | |||||
| Price-to-Operating-Cash-Flow | 7.3 | |||||
| EV-to-EBIT | 23.11 | |||||
| EV-to-EBITDA | 22.73 | |||||
| EV-to-Revenue | 0.95 | |||||
| EV-to-FCF | 10.07 | |||||
| Price-to-Projected-FCF | 0.76 | |||||
| Price-to-Graham-Number | 0.26 | |||||
| Price-to-Net-Current-Asset-Value | 16.95 | |||||
| Earnings Yield (Greenblatt) % | 4.33 | |||||
| FCF Yield % | 13.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vivanza Biosciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 210.458 | ||
| EPS (TTM) (₹) | -0.036 | ||
| Beta | -0.49 | ||
| Volatility % | 64.76 | ||
| 14-Day RSI | 30.43 | ||
| 14-Day ATR (₹) | 0.092871 | ||
| 20-Day SMA (₹) | 3.9155 | ||
| 12-1 Month Momentum % | -61.36 | ||
| 52-Week Range (₹) | 3.7 - 13.8 | ||
| Shares Outstanding (Mil) | 40 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vivanza Biosciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vivanza Biosciences Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vivanza Biosciences Ltd Frequently Asked Questions
What is Vivanza Biosciences Ltd(BOM:530057)'s stock price today?
The current price of BOM:530057 is ₹3.73. The 52 week high of BOM:530057 is ₹13.80 and 52 week low is ₹3.70.
When is next earnings date of Vivanza Biosciences Ltd(BOM:530057)?
The next earnings date of Vivanza Biosciences Ltd(BOM:530057) is .
Does Vivanza Biosciences Ltd(BOM:530057) pay dividends? If so, how much?
Vivanza Biosciences Ltd(BOM:530057) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers